In India alone, close to 74 million people are diabetic, with a growing number requiring insulin therapy
Read More
Obese children are four times more likely to develop type 2 diabetes mellitus compared to those of normal weight
Read More
Diabetes, particularly Type 2 diabetes mellitus (T2DM), is a significant health issue that affects millions globally. In India alone, T2DM impacts approximately 77 million adults, with projections estimating this figure to rise to 134 million by 2045.
Read More_20241004173520_original_image_15.webp)
Experts are attributing this alarming trend to lifestyle factors such as rising rates of obesity, diabetes, and hypertension
Read More_20241004122908_original_image_36.webp)
Data from the Mckinsey & Company indicates that nearly 79 per cent of all deaths worldwide were caused due to people suffering from chronic diseases like cardiovascular disease, cancer, diabetes, and respiratory diseases
Read More
The findings come amid global debates over the use of NNSs for weight management and diabetes control, with recent WHO guidelines raising concerns primarily for non-diabetic individuals
Read More
Hypertension and diabetes are prevalent lifestyle diseases in India, with over 50 per cent of hypertensive patients also diagnosed with T2DM
Read More
By replicating normal physiological processes, the Micro Dose System (MDS) significantly reduces insulin resistance, enhancing the absorption of blood sugar into cells and its conversion into energy
Read More_20240627184413_original_image_6.webp)
Based on 23 human clinical trials, the study indicates that such diets contribute to a host of metabolic disorders, including diabetes, cardiovascular diseases (CVD), polycystic ovary syndrome (PCOS), non-alcoholic fatty liver disease (NAFLD), and obesity
Read More
India holds approximately 25 per cent of the global lung infection burden, and among adults over 50, one out of five cases of pneumococcal infections leads to mortality
Read More
